The U.S. Rosacea Market: Size, Trends & Forecasts (2020-2024 Edition)

Foamix Pharmaceuticals Ltd., Galderma, Sol-Gel Technologies Ltd., and Allergan Plc are some of the major players whose company profiling has been done in the report. This segment of the report summarizes business overview, financial overview.
 
 
Spread the Word
Listed Under

Tag:
Usa Rosacea Market

Industry:
Reports

Location:
Delhi - Delhi - India

Subject:
Reports

DELHI, India - March 17, 2020 - PRLog -- The report entitled "The U.S. Rosacea Market: Size, Trends & Forecasts (2020-2024 Edition)", provides a detailed analysis of the U.S. rosacea market with market sizing and growth pattern. The analysis includes rosacea market in terms of value, volume and number of patients seeking treatment. The report also provides an overview of the U.S. dermatology drugs market in terms of value and market share by segments.

Furthermore, the report also assesses the key opportunities available in the market and summarizes the dynamic forces that are and will be accountable for growth of the industry. Growth of the U.S. rosacea market has also been forecasted for the period 2020-2024, taking into consideration previous growth outlines, growth drivers and the existing and forthcoming trends.

Foamix Pharmaceuticals Ltd., Galderma, Sol-Gel Technologies Ltd., and Allergan Plc are some of the major players whose company profiling has been done in the report.

Company Coverage

Foamix Pharmaceuticals Ltd.
Sol-Gel Technologies Ltd
Galderma
Allergan Plc

Executive Summary

Rosacea is a common disorder associated with skin and most prevalent among people with light skin tone, and mainly affects areas around the chin, cheeks, nose, and forehead. The main characteristic of this disease is solid-bumps and pus-filled pimples.

Rosacea is a common chronic condition of the skin with a high prevalence rate among the U.S. population. It naturally begins at any time after the age of 30 or previously. In some cases, rosacea may also occur on the neck, chest, scalp or ears. Rosacea symptoms and signs include facial flushing, fine red vascular lines, swollen, red eyelids and many more. Currently, more than 16 million populations in the U.S. are suffering from rosacea.

The U.S. rosacea market has grown over the past few years and is projected to grow at a high growth rate on the back of rising incidence of disease, and aging population. The growth in the market will be driven by unhealthy eating habits and environmental factors, rising disposable income, ageing population, escalating healthcare expenditure, high prevalence of rosacea, etc. Yet the market growth is restrained by factors such as lack of awareness and knowledge and stringent government regulations for the approval of new drugs.

For further details, kindly visit :

https://www.daedal-research.com/pharma-healthcare/the-us-rosacea-market-size-trends-forecasts-2020-2024-edition

Rajeev Kumar

(Business Development Manager)

Address:  36 SFS Flats

Paschim Vihar

New Delhi-110063

Mobile: +91-9811715635

Tel: +91-120-4553017

Mail ID - info@daedal-research.com

Contact
Rajeev Kumar
info@daedal-research.com
+91-9811715635
End
Email:***@daedal-research.com Email Verified
Tags:Usa Rosacea Market
Industry:Reports
Location:Delhi - Delhi - India
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share